02.04.2020 • News

Nouryon Expands Peroxides Partnership with Sumitomo

Nouryon Expands Peroxides Partnership with Sumitomo (c) Nouryon
Nouryon Expands Peroxides Partnership with Sumitomo (c) Nouryon

Nouryon is expanding its partnership with Sumitomo Chemical to include a manufacturing facility the Japanese company is building at its site in Oita.

The new plant, to be owned and operated by Sumitomo, will supply 1,3-diisopropanolbenzene (DIOL), which is a key raw material for Nouryon’s Perkadox 14 organic peroxide. Start-up is due in 2021.

Perkadox 14 is used to make a variety of elastomeric products, including shoe soles, yoga mats and other rubber goods.

 “We have a strong relationship with Sumitomo, which has supplied DIOL to us from Chiba for the past four years,” said Alain Rynwalt, vice president of polymer catalysts at Nouryon. “In response to increased customer demand for our organic peroxides in Asia, we worked with Sumitomo to develop a plant in Oita to help ensure security of supply.”

Johan Landfors, Nouryon’s president of technology solutions, added that the agreement is “a great example of partnering with a supplier to support our strategy of expanding in attractive growth markets.”

Nouryon produces Perkadox 14 at Mons, Belgium, and Ningbo, China, where it completed a project last June that lifted capacity by 25%.

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read